Freenome, Inc. (PCSC) Stock Price & Analysis
Freenome, Inc. (PCSC) rose 0.00% to USD 11.95 as of July 26, 2026 at 07:07 UTC, according to Nexqual real-time market data.
PCSC last closed at USD 11.95; the session ranged USD 11.95–11.95 on volume of 103,023 shares. Market capitalization is $123.25M, with a 52-week range of USD 9.95–14.47 (NGM). Source: Nexqual, July 26, 2026 at 07:07 UTC.
Key Statistics (as of July 26, 2026 at 07:07 UTC)
| Price | USD 11.95 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.95 |
| Open | USD 12.02 |
| Day Range | USD 11.95 – 11.95 |
| 52-Week Range | USD 9.95 – 14.47 |
| Volume | 103,023 shares |
| Market Cap | $123.25M |
| Exchange | NGM |
Technical Analysis (PCSC)
Nexqual's technical model rates PCSC "BUY" based on 5 bullish and 1 bearish signals across 120 daily candles, as of July 26, 2026 at 07:07 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.81 (neutral) |
| vs SMA50 | Above (USD 11.2) |
| MACD | 0.17 (positive) |
Analyst Ratings (PCSC)
Wall Street analysts rate PCSC "None", per Nexqual as of July 26, 2026 at 07:07 UTC.
| Consensus Rating | None |
|---|
Earnings (PCSC)
Source: Nexqual, July 26, 2026 at 07:07 UTC.
Financials & Fundamentals (PCSC)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.21 |
| Total Cash | $437,369 |
| Total Debt | $0 |
Source: Nexqual, July 26, 2026 at 07:07 UTC.
Financial Health Score (PCSC)
Nexqual rates Freenome, Inc.'s overall financial health "Weak" across five dimensions, as of July 26, 2026 at 07:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $437K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$907K |
| Efficiency | Mixed — No data |
Ownership (PCSC)
| Insider Ownership | +0.25% |
|---|---|
| Institutional Ownership | +9.99% |
| Shares Outstanding | 8.16M |
| Float | 2.10M |
| Short % of Float | +9.17% |
Source: Nexqual, July 26, 2026 at 07:07 UTC.
Leadership (PCSC)
Freenome, Inc. is led by Adam Leo Stone (age 45), CEO & Director, per Nexqual as of July 26, 2026 at 07:07 UTC.
| CEO & Director | Adam Leo Stone (age 45) |
|---|---|
| Chief Financial Officer | Shmuel M. Cohn (age 38) |
| Chief Business Officer & Director | Michael Seth Altman C.F.A. (age 43) |
Major Backers & Investors (PCSC)
Notable institutional backers of Freenome, Inc. include Farallon Capital Management LLC, One Fin Capital Management LP, RA Capital Management, L.P., according to Nexqual as of July 26, 2026 at 07:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Farallon Capital Management LLC | 27.58% |
| One Fin Capital Management LP | 10.34% |
| RA Capital Management, L.P. | 9.19% |
| RTW Investments LP | 9.1% |
| BIT Capital GmbH | 9.07% |
| Holocene Advisors, LP | 7.66% |
| Aberdeen Group plc | 7.09% |
| 683 Capital Management LLC | 6.89% |
Source: Nexqual, July 26, 2026 at 07:07 UTC.
From Freenome, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires.
Partnerships
- Our selection process leverages our relationships with leading venture capitalists and growth equity funds, executives of private and public companies, as well as leading investment banking firms, which we believe will provide us with a key competitive advantage in sourcing potential business combination targets.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IBAC | IB Acquisition Corp. | USD 10.79 | ▲ 0% |
| BKHA | Black Hawk Acquisition Corporat | USD 12.1 | ▼ 7.63% |
| MACI | Melar Acquisition Corp. I | USD 10.9 | ▲ 0% |
| CTNM | Contineum Therapeutics, Inc. | USD 14.06 | ▼ 4.55% |
| MBAV | M3-Brigade Acquisition V Corp. | USD 11.14 | ▲ 4.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 07:07 UTC. This page is informational and not investment advice.